Manish Chandra Choudhary, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Viral Load | 6 | 2024 | 3396 | 0.680 |
Why?
|
Hepacivirus | 2 | 2014 | 1344 | 0.560 |
Why?
|
Hepatitis C | 3 | 2014 | 1595 | 0.510 |
Why?
|
Dengue Virus | 1 | 2017 | 204 | 0.490 |
Why?
|
Dengue | 1 | 2017 | 258 | 0.450 |
Why?
|
Drug Resistance, Viral | 4 | 2024 | 869 | 0.390 |
Why?
|
Virus Shedding | 2 | 2022 | 110 | 0.380 |
Why?
|
Evolution, Molecular | 2 | 2021 | 1896 | 0.360 |
Why?
|
Genotype | 2 | 2014 | 13045 | 0.340 |
Why?
|
Cell Lineage | 1 | 2017 | 2575 | 0.300 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1761 | 0.290 |
Why?
|
Antibodies, Viral | 7 | 2024 | 3214 | 0.280 |
Why?
|
Phylogeny | 4 | 2022 | 2843 | 0.280 |
Why?
|
Bayes Theorem | 1 | 2014 | 2359 | 0.260 |
Why?
|
India | 4 | 2018 | 2334 | 0.260 |
Why?
|
Immunocompromised Host | 2 | 2021 | 863 | 0.250 |
Why?
|
Antiviral Agents | 4 | 2024 | 3072 | 0.240 |
Why?
|
Antibodies, Monoclonal | 5 | 2024 | 9262 | 0.230 |
Why?
|
Antibodies, Neutralizing | 6 | 2024 | 2009 | 0.230 |
Why?
|
Adenosine Monophosphate | 1 | 2024 | 232 | 0.210 |
Why?
|
Virus Cultivation | 1 | 2022 | 88 | 0.200 |
Why?
|
Immunization, Passive | 2 | 2022 | 619 | 0.200 |
Why?
|
Respiratory Syncytial Virus Vaccines | 1 | 2022 | 37 | 0.200 |
Why?
|
Alanine | 1 | 2024 | 614 | 0.190 |
Why?
|
SAIDS Vaccines | 1 | 2022 | 144 | 0.190 |
Why?
|
Immune Evasion | 2 | 2023 | 375 | 0.180 |
Why?
|
Genome, Viral | 2 | 2014 | 674 | 0.180 |
Why?
|
RNA, Viral | 5 | 2023 | 2874 | 0.170 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2021 | 446 | 0.160 |
Why?
|
Virulence Factors | 1 | 2023 | 502 | 0.160 |
Why?
|
Virulence | 1 | 2023 | 1297 | 0.160 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 167 | 0.160 |
Why?
|
Disease Reservoirs | 1 | 2018 | 123 | 0.150 |
Why?
|
Virus Replication | 2 | 2023 | 2458 | 0.140 |
Why?
|
Endemic Diseases | 1 | 2018 | 191 | 0.140 |
Why?
|
Hepatitis E | 1 | 2018 | 76 | 0.140 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 283 | 0.140 |
Why?
|
Serotyping | 1 | 2017 | 331 | 0.140 |
Why?
|
Hepatitis, Alcoholic | 1 | 2018 | 110 | 0.130 |
Why?
|
Papillomavirus Vaccines | 1 | 2022 | 497 | 0.130 |
Why?
|
AIDS Vaccines | 1 | 2022 | 900 | 0.130 |
Why?
|
Iron Overload | 1 | 2018 | 245 | 0.130 |
Why?
|
Influenza Vaccines | 1 | 2022 | 781 | 0.120 |
Why?
|
Hepatitis B virus | 1 | 2018 | 533 | 0.120 |
Why?
|
Mutation | 7 | 2024 | 30237 | 0.120 |
Why?
|
Drug Therapy, Combination | 1 | 2024 | 6316 | 0.110 |
Why?
|
Humans | 34 | 2024 | 768171 | 0.110 |
Why?
|
DNA, Viral | 1 | 2018 | 2204 | 0.100 |
Why?
|
Ritonavir | 2 | 2023 | 332 | 0.090 |
Why?
|
Sequence Alignment | 1 | 2014 | 2179 | 0.090 |
Why?
|
Antigens, CD | 2 | 2018 | 4035 | 0.090 |
Why?
|
Iron | 1 | 2018 | 1813 | 0.080 |
Why?
|
Adult | 12 | 2024 | 223646 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2819 | 0.080 |
Why?
|
Kinetics | 2 | 2024 | 6330 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2018 | 2401 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 1816 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2021 | 4573 | 0.060 |
Why?
|
Middle Aged | 9 | 2024 | 223487 | 0.060 |
Why?
|
Male | 11 | 2024 | 364731 | 0.060 |
Why?
|
HIV-1 | 1 | 2021 | 6963 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4786 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Infant | 2 | 2022 | 36535 | 0.050 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 13422 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2022 | 52 | 0.050 |
Why?
|
Convalescence | 1 | 2022 | 107 | 0.050 |
Why?
|
Half-Life | 1 | 2023 | 651 | 0.050 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2022 | 71 | 0.050 |
Why?
|
Inflammation | 2 | 2020 | 10873 | 0.050 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17623 | 0.050 |
Why?
|
Vero Cells | 1 | 2022 | 485 | 0.050 |
Why?
|
HIV Infections | 2 | 2021 | 17569 | 0.050 |
Why?
|
Female | 9 | 2024 | 397187 | 0.040 |
Why?
|
Neutralization Tests | 1 | 2022 | 739 | 0.040 |
Why?
|
BCG Vaccine | 1 | 2022 | 381 | 0.040 |
Why?
|
Genetic Variation | 1 | 2014 | 6610 | 0.040 |
Why?
|
Aged | 4 | 2024 | 171502 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2021 | 19025 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1737 | 0.040 |
Why?
|
Viremia | 1 | 2020 | 726 | 0.040 |
Why?
|
Cell Line, Transformed | 1 | 2018 | 866 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1250 | 0.030 |
Why?
|
Hepatitis E virus | 1 | 2018 | 72 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1743 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1836 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 840 | 0.030 |
Why?
|
South Africa | 1 | 2021 | 1873 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2018 | 557 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1511 | 0.030 |
Why?
|
Treatment Failure | 1 | 2021 | 2661 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 2089 | 0.030 |
Why?
|
Hepatitis B | 1 | 2018 | 711 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2023 | 81760 | 0.030 |
Why?
|
Prospective Studies | 3 | 2024 | 54924 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4280 | 0.020 |
Why?
|
Hepatocytes | 1 | 2018 | 1247 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8747 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3229 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3437 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2023 | 12466 | 0.020 |
Why?
|
Cell Line | 1 | 2023 | 15602 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3858 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2013 | 1864 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9343 | 0.020 |
Why?
|
Health Personnel | 1 | 2022 | 3384 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8890 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 60066 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2018 | 3140 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4355 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2013 | 1377 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2013 | 1854 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2018 | 2334 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10397 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14783 | 0.010 |
Why?
|
Lung | 1 | 2023 | 10101 | 0.010 |
Why?
|
Incidence | 1 | 2022 | 21538 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9384 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4363 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15949 | 0.010 |
Why?
|
Liver | 1 | 2018 | 7578 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12795 | 0.010 |
Why?
|
Cohort Studies | 1 | 2024 | 41753 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26421 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10840 | 0.010 |
Why?
|
Animals | 2 | 2023 | 169285 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22290 | 0.010 |
Why?
|
Time Factors | 1 | 2022 | 40220 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42669 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7452 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10478 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7876 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39354 | 0.010 |
Why?
|
Mice | 1 | 2023 | 82049 | 0.010 |
Why?
|
Child | 1 | 2021 | 80917 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 89169 | 0.010 |
Why?
|